about
Differences in procedural knowledge after a "spaced" and a "massed" version of an intensive course in emergency medicine, investigating a very short spacing intervalAngiopoietin 1 and 2 gene and protein expression is differentially regulated in acute anti-Thy1.1 glomerulonephritisMagnesium stimulates renal phosphate reabsorptionDecreased renal corin expression contributes to sodium retention in proteinuric kidney diseasesLearning management system and e-learning tools: an experience of medical students' usage and expectationsSurvey of e-learning implementation and faculty support strategies in a cluster of mid-European medical schools.Tyrosine kinases inhibition by Imatinib slows progression in chronic anti-thy1 glomerulosclerosis of the ratCardiac and renal function in a large cohort of amateur marathon runners.A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.FTY720: early clinical experience.Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy.IL-17 Expression in the Time Course of Acute Anti-Thy1 Glomerulonephritis.Evaluation of the free, open source software WordPress as electronic portfolio system in undergraduate medical educationSafety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study.Pharmacological management of renal fibrotic disease.FTY720 (fingolimod) in renal transplantation.Current perspectives on FTY720.Hepatitis B in chronic kidney disease: moving toward effective prevention.NO signaling through cGMP in renal tissue fibrosis and beyond: key pathway and novel therapeutic target.Tubular von Hippel-Lindau knockout protects against rhabdomyolysis-induced AKI.Nephrogenic systemic fibrosis versus contrast-induced nephropathy: risks and benefits of contrast-enhanced MR and CT in renally impaired patients.Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy.Applying occupational and organizational psychology theory to entrustment decision-making about trainees in health care: a conceptual modelSuperior Gain in Knowledge by Podcasts Versus Text-Based Learning in Teaching Orthopedics: A Randomized Controlled Trial.Impact of biological gender and soluble guanylate cyclase stimulation on renal recovery after relief of unilateral ureteral obstruction.Stimulation of soluble guanylate cyclase improves renal recovery after relief of unilateral ureteral obstruction.Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.Angiotensin II and L-arginine in tissue fibrosis: more than blood pressure.Medical students' preparedness for professional activities in early clerkships.Berlin in Motion: Interprofessional teaching and learning for students in the fields of medicine, occupational therapy, physiotherapy and nursing (INTER-M-E-P-P).S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation.L-arginine supplementation accelerates renal fibrosis and shortens life span in experimental lupus nephritis.Angiotensin-converting enzyme inhibition but not beta-adrenergic blockade limits transforming growth factor-beta overexpression in acute normotensive anti-thy1 glomerulonephritis.NO mediates antifibrotic actions of L-arginine supplementation following induction of anti-thy1 glomerulonephritis.Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritis.The Sphingosine-1 Phosphate receptor agonist FTY720 dose dependently affected endothelial integrity in vitro and aggravated ventilator-induced lung injury in mice.Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis.
P50
Q27308061-1680817D-2BC8-4795-86A5-622CC9F4FC64Q28572274-4A5BA08D-F275-444A-9E98-03E939E993AEQ28576857-44E982F3-D465-4779-A850-3AC0C7E4D32AQ28584012-A8E60177-C732-4C88-BB7B-D71E7B8E56F2Q28595968-9BDD2277-D9D5-4611-87F4-B00103EC44E6Q30663711-8A8CCBEB-1651-4DD4-BA2C-F032376E4424Q35015952-11F4638D-97C5-426F-8AB8-C3B4903AC532Q35213651-9E2D9229-BB35-48E1-99A8-752226165420Q35669295-020F5662-8D63-42EC-A8E2-B2AA254CA874Q35711520-5A57EF97-D1AE-4889-ADE9-DDEB4EAB1437Q35959002-1835A342-5701-4CE1-B3DF-A018055B06CCQ36034788-80E67FF9-E107-496D-9197-D3E5BE533945Q36038833-22570504-AE08-47A7-98E3-26A36E7129DCQ36104484-1FEB1947-5783-42C8-8AF7-AA34B9D5C573Q36407348-92E59603-65B9-4404-A778-3D1345FA5D63Q36652022-A865C338-E1E8-40B8-B97C-0051C3D58DE8Q36764024-FF78FC1F-562A-4B4D-B0CA-F378C004FF92Q37109951-9D82D079-00F9-4A6B-B810-85AFEA212C20Q37184953-21ECC5A4-57E3-4736-BA3C-587F6D4484A0Q37260233-13E96734-94BE-4716-A014-A0E34B71A301Q37638581-6F8587D0-A407-4F2A-8348-18FB3BF2BE09Q37639909-073B9AFA-9946-4815-A00A-83168BBC11B4Q37740388-D4F61771-EA3C-4B20-95FA-96756E4C0F8DQ38546402-EB7C9857-2848-443A-A9B7-11581C716867Q39247650-4847DF4E-E6BF-425D-A4B5-1910EED6A43CQ39262152-C53D1D17-DE4F-470E-8ACC-60BBEDDC6EA5Q40885799-FF1FEAA6-8D91-46F0-9997-9B6D1F489F26Q41469780-C9FC1498-5498-44C4-956C-5840A94A0FABQ41497331-DDB9CA2A-346A-4C95-95F0-14B3E670A018Q41853698-20A42DA2-285D-4ED1-86C4-5023E8B03992Q42170445-E3678A4D-AB4A-4AE3-8E9C-D341F97F692EQ42471113-F2E57ED3-F95A-48F8-B249-1E987C1543E0Q42479831-0C35C5E2-2C88-49F2-A512-4D49CBAAD8FBQ44232604-678BDE28-DA4A-4647-B1F5-8A9B2E24F282Q44358741-67E5C0E8-D4A9-41AB-B3CD-871559AC1039Q44376923-C83ED6F2-D8AF-441D-AF19-1DAAC0753906Q44503836-36C86109-85BA-4C8C-84A6-DD874F951610Q44900453-312D3198-B185-43EC-BD3B-C50165E01E2AQ45026785-FE766F36-B50D-4217-82BE-96A1DE0EA8C8Q45085845-693F79F1-08B0-4E79-8589-5C149603D3B2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Harm Peters
@ast
Harm Peters
@en
Harm Peters
@es
Harm Peters
@nl
Harm Peters
@sl
type
label
Harm Peters
@ast
Harm Peters
@en
Harm Peters
@es
Harm Peters
@nl
Harm Peters
@sl
altLabel
Peters H
@en
prefLabel
Harm Peters
@ast
Harm Peters
@en
Harm Peters
@es
Harm Peters
@nl
Harm Peters
@sl
P106
P108
P1153
57004329400
P21
P31
P4012
P496
0000-0003-1441-7512
P569
2000-01-01T00:00:00Z